Objectives To determine the efficacy and safety of ondansetron for the prevention and
treatment of postoperative nausea and vomiting (PONV) in adults. Design Systematic review …

Background: We evaluated whether or not 1) a routine prophylaxis with 20 μg· kg− 1 body
weight of droperidol would efficiently prevent postoperative nausea and vomiting (PONV) …

In this placebo controlled, double blind multicentre study, the efficacy and safety of a single
iv bolus dose of ondansetron 4 mg were evaluated in the prevention of postoperative …

In this study the antiemetic effects of droperidol, ondansetron and their combination were
evaluated in 160 ASA Grade I and II children undergoing surgery for strabismus, who were …

Background Palonosetron is a new, potent, and long-acting 5HT3-receptors antagonist that
had been approved by the FDA for use in postoperative nausea and vomiting (PONV) …

This study compares the preoperative administration of ondansetron with that of droperidol
or saline solution for the prevention of nausea and vomiting in otologic surgery patients. A …

Prospective application of a simplified risk score to prevent postoperative nausea and
vomiting Page 1 Purpose: To compare the risk-adapted approach with ondansetron against …

In order to verify the efficacy and safety of a single intravenous dose of ondansetron in the
prevention of postoperative nausea and vomiting (PONV), 928 patients undergoing …

Postoperative nausea and vomiting (PONV) has many causes, including anaesthetic drugs.
Choice of induction agent may affect the incidence of PONV, though the evidence is …

The MEDLINE database for the years 1995–1998 contains 188 reports of clinical trials
involving different therapeutic regimens for the management of postoperative nausea and …